# Onset Mechanisms and Prognosis of Neurally Mediated Syncope

## TL;DR

This study explores the mechanisms and prognosis of neurally mediated syncope by analyzing gene polymorphisms and physiological responses.

## Contribution

The study identifies gene-related differences and physiological markers that may help assess the risk of syncope onset.

## Key findings

- Patients with vasodepressor NMS showed increased AC activity and decreased systolic blood pressure.
- High SBP and elevated AC activity at rest are likely to cause syncope.
- Negative HUT test results are associated with a high incidence of cardiovascular events.

## Abstract

Neurally mediated syncope (NMS) is associated with a sudden loss of consciousness. However, the diagnostic tools and measures for prognosis management are limited. To overcome these limitations, the differences in the binding energies of Giα-protein-coupled receptors to the Glu9 and Glu12 residues on the α2B-AR gene were elucidated through the analysis of α2B-AR gene polymorphism. The suppression of the activity of adenylate cyclase (AC), which is involved in vasoconstriction, may be related to the onset of NMS. The head-up tilt (HUT) test results indicated differences in systolic blood pressure (SBP) and AC activity between patients with vasodepressor (VT)-NMS and healthy volunteers. Patients with VT-NMS had increased AC activity and decreased SBP. Conversely, in healthy volunteers, no changes in AC activity or SBP were found. These findings suggest that a high SBP and elevated AC activity at rest are likely to cause syncope. A high incidence of cardiovascular events is found in patients with negative HUT test results, highlighting the importance of investigating the cause of syncope in cases where the HUT test results are negative. Overall, our results may provide a means of assessing the risk of NMS development within healthy populations and underscore the importance of subsequent treatments for NMS.